Role for ZAP-70 signaling in the differential effector functions of rituximab and obinutuzumab (GA101) in chronic lymphocytic leukemia B cells

Sladjana Skopelja-Gardner, Jonathan D. Jones, B. Jonell Hamilton, Alexey Danilov, William F.C. Rigby

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint Dive into the research topics of 'Role for ZAP-70 signaling in the differential effector functions of rituximab and obinutuzumab (GA101) in chronic lymphocytic leukemia B cells'. Together they form a unique fingerprint.

Medicine & Life Sciences